Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Mais filtros










Filtros aplicados
  • País/Região como assunto
Intervalo de ano de publicação
1.
Acta pediátr. hondu ; 11(1): 1096-1102, abr.- sept. 2020. tab, map, graf
Artigo em Espanhol | LILACS | ID: biblio-1140359

RESUMO

Antecedentes: El 31 de diciembre de 2019, Chi-na comunicó un reporte de casos de neumonía de etiología desconocida. El 11 de febrero de 2020, la Organización Mundial de la Salud (OMS) de-nominó a la enfermedad por coronavirus 2019: COVID-19.(1) En América Latina el primer caso se confirmó el 25 de febrero de 2020 en Brasil.(2) En Honduras se confirmaron los dos primeros casos de COVID-19 el 10 de marzo,(3) y el primer caso en edad pediátrica en San Pedro Sula (S.P.S.) se confirmó el 25 de marzo de 2020.(4)Objetivo: Caracterizar clínica y epidemiológicamente la enfermedad por coronavirus 2019 en la edad pediátrica en S.P.S., Honduras. Pacientes y mé-todos: Estudio cuantitativo, descriptivo, y trans-versal. Se utilizó un muestreo no probabilístico de 415 pacientes en edad pediátrica (IC 95%) a quienes se les realizó una prueba de reacción en cadena de la polimerasa en tiempo real (PCR-tr). Las variables estudiadas fueron: sociodemográ-ficas, curso de la enfermedad, manifestaciones clínicas, factores de riesgo, manejo del pacien-te, condición actual del paciente y distribución según el establecimiento de salud notificante. La información recolectada fue ingresada en una base de datos y analizada en Microsoft Ex-cel. Resultados: 170 (40.96%) pacientes en edad pediátrica resultaron positivos. El grupo etáreo más afectado fueron los adolescentes (54.71%). El curso de la enfermedad fue sintomático en 124 pacientes. El síntoma que más frecuentemente se reportó fue fiebre (37.10%). A la fecha de finalización del estudio, 152 con-tinuaban activos con COVID-19. Conclusiones: Este estudio resume las principales característi-cas clínicas y epidemiológicas de la COVID-19 en niños y adolescentes de S.P.S...(AU)


Assuntos
Humanos , Criança , Reação em Cadeia da Polimerase/métodos , Infecções por Coronavirus/transmissão , Pneumonia/complicações , Insuficiência Respiratória
3.
Washington, D.C.; PAHO; 2020-08-05. (PAHO/FPL/IM/COVID-19/20-0013).
Não convencional em Inglês | PAHO-IRIS | ID: phr-52544

RESUMO

Both the World Health Organization (WHO) and the Pan American Health Organization (PAHO) have recommended that uninterrupted vaccination be maintained as an essential health service. To this end, PAHO's Comprehensive Family Immunization Unit of the Family, Health Promotion, and Life Course Department has worked assiduously with the countries of the Region to maintain sound national immunization programs on several fronts, such as the preparation of documents and guidelines for continuing vaccination in the context of COVID-19; monitoring the disease’s impact on vaccination coverage; assessing the effects of the postponement of measles vaccination campaigns (Plurinational State of Bolivia, Colombia, Dominican Republic, Honduras, Paraguay) due to the pandemic; and strengthening vaccination against seasonal influenza. The data presented in this publication were collected through a survey, sent every two weeks to IM focal points and advisors in the at PAHO country offices in the Region. The SurveyMonkey virtual platform was used and the data were analyzed with MS Excel tools. All the variables included in the survey were described using the appropriate univariate statistics. Categorical variables were described using proportions and percentages. Ordinal variables were described using the mean and median. Work has also been carried out to monitor the functioning of immunization services and the main problems they face because of the pandemic. To date, five-country surveys have been conducted; the first was sent out on 16 April, the last on 6 July. This document summarizes the surveys' main findings and developments. The responses in this report represent the opinions of survey participants, and do not represent reports officially sent or solicited by PAHO; the data should, therefore, be interpreted with caution.


Assuntos
Coronavirus , Infecções por Coronavirus , Imunização , Cobertura Vacinal , Prioridades em Saúde , Serviços de Saúde , Bolívia , Colômbia , República Dominicana , Honduras , Paraguai
5.
Clin Infect Dis ; 2020 Aug 17.
Artigo em Inglês | MEDLINE | ID: mdl-32803236

RESUMO

BACKGROUND: The SARS-CoV-2 pandemic has caused substantial morbidity and mortality worldwide. Few reports exist in Latin America, a current epicenter of transmission. Here, we aim to describe the epidemiology and outcomes associated with COVID-19 in Honduras. METHODS: Baseline clinical and epidemiological information of SARS-CoV-2 RT-PCR confirmed cases detected between March 17th-May 4th in the San Pedro Sula Metropolitan area was collected, and, for hospitalized cases, clinical data was abstracted. Logistic regression models were fit to determine factors associated with hospitalization. RESULTS: 877 COVID-19 cases were identified of which 25% (n=220) were hospitalized. The 19-44-year age group (57.8%) and males (61.3%) were predominant in overall COVID-19 cases. 34% of the cases (n=299) had at least one pre-existing medical condition. Individuals aged 45-69 years [aOR= 4.05, 95% CI: 2.85-5.76], ≥70 years [aOR= 9.12, 95% CI:5.24-15.86], of male sex [aOR =1.72, CI 95%: 1.21-2.44] and those with a pre-existing condition [aOR= 2.12, 95% CI: 1.43-3.14] had a higher odd of hospitalization. Fifty percent of inpatients were hospitalized more than 7 days. Median length of hospitalization was 13 days [IQR: 8-29] among individuals aged 19-44 years, and 17 days [IQR: 11-24.6] among those aged 45-69. Forty-two percent of the fatal cases occurred among adults under 60 years old. CONCLUSIONS: Our findings show that a high proportion of COVID-19 cases in Honduras occurred among younger adults, who also constituted a significant proportion of severe and fatal cases. Pre-existing conditions were associated with severe outcomes independently from age and were highly prevalent in Honduran COVID-19 cases.

6.
Bogotá; Organización Panamericana de la Salud; jul. 17, 2020. 13 p.
Não convencional em Espanhol | LILACS | ID: biblio-1103541

RESUMO

Este documento tiene el propósito de actualizar las líneas de acción estratégicas de la OPS/OMS para el abordaje de la epidemia de la COVID-19 en Honduras. La pandemia ha tenido una evolución acelerada a nivel mundial, considerándose de una gravedad alta con impactos que van mucho más allá del sector salud y que han perturbado todos los aspectos sociales y económicos de casi todos los países del mundo. Por lo tanto, es necesario ir adaptando y actualizando las intervenciones para que reflejen de mejor manera las lecciones aprendidas de otros países, los mandatos y las necesidades nacionales y las recomendaciones de la Organización Mundial de la Salud/Organización Panamericana de la Salud, de acuerdo con las políticas emergentes tanto al nivel nacional, subregional y mundial.


Assuntos
Pneumonia Viral/prevenção & controle , Infecções por Coronavirus/prevenção & controle , Pandemias/prevenção & controle , Betacoronavirus , Estratégias Nacionais , Planejamento , Promoção da Saúde/organização & administração , Honduras
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA